Cargando…
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients with Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study
Acute myeloid leukemia (AML) is a disease affecting older adults, although optimal strategies for treating such patients remain unclear. This prospective phase II, open-label, multicenter study was designed to assess the efficacy and safety of two hematologic growth factors, recombinant human thromb...
Autores principales: | Liu, Xiaoyu, Shi, Hua, Shen, Jing, Li, Yang, Yan, Wei, Sun, Ying, Liao, Aijun, Tan, Yehui, Yang, Wei, Wang, Huihan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485918/ https://www.ncbi.nlm.nih.gov/pubmed/34611424 http://dx.doi.org/10.2147/IJGM.S323699 |
Ejemplares similares
-
Management of COVID-19-related immune thrombocytopenia by rhTPO
por: Zhang, Xuzhao, et al.
Publicado: (2021) -
rhTPO Ameliorates Radiation-Induced Long-Term Hematopoietic Stem Cell Injury in Mice
por: Luan, Hao, et al.
Publicado: (2023) -
rhTPO combined with chemotherapy and G-CSF for autologous peripheral blood stem cells in patients with refractory/relapsed non-Hodgkin’s lymphoma
por: Zhu, Jun, et al.
Publicado: (2019) -
A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced Thrombocytopenia
por: Zhu, Qiuhua, et al.
Publicado: (2021) -
A Randomized Controlled Study of rhTPO and rhIL-11 for the Prophylactic Treatment of Chemotherapy-Induced Thrombocytopenia in Non-Small Cell Lung Cancer
por: Xu, Yunhua, et al.
Publicado: (2018)